Endocare Inc.: The Irvine manufacturer of devices...

Endocare Inc.: The Irvine manufacturer of devices to treat prostate diseases reported a second-quarter net loss of $394,557, or 7 cents a share, compared with a net loss of $181,720 for the 1995 second quarter. Endocare was spun off from Medstone International Inc. earlier this year and became a publicly held company in February. Revenue rose 31% to $419,785 from $319,898. For the first half, the company recorded a net loss of $972,141, or 17 cents a share, compared with a net loss of $272,737 a year earlier. Revenue advanced 14% to $790,441 from $695,988.